Loading
Latest filing published 16 Jul 2026 for ME Therapeutics Holdings Inc., €309k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Kenneth Harder in ME Therapeutics Holdings Inc. Between 31 March 2026 and 16 July 2026, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 16 July 2026 with an option exercise (€309k) in ME Therapeutics Holdings Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations